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Background: Streptococcus suis is a zoonotic disease mainly affecting men of working age and can result in
death or long-term sequelae, including severe hearing loss and vestibular dysfunction. We aimed to quantify
the burden of disease and economic impact of this infection in Viet Nam.
Methods: The annual disease incidence for the period 2011–2014 was estimated based on surveillance data
using a multiple imputation approach. We calculated disease burden in disability-adjusted life years (DALYs)
and economic costs using an incidence-based approach from a patient’s perspective and including direct and
indirect impacts of S. suis infection and its long-term sequelae.
Results: The estimated annual incidence rate was 0.318, 0.324, 0.255 and 0.249 cases per 100 000 popu-
lation in 2011, 2012, 2013 and 2014, respectively. The corresponding DALYs lost were 1832, 1866, 1467
and 1437. The mean direct cost per episode was US$1635 (95% confidence interval 1352–1923). The
annual direct cost was US$370 000–500 000 and the indirect cost was US$2.27–2.88 million in this time
period.
Conclusions: This study showed a large disease burden and high economic impact of S. suis infection and pro-
vides important data for disease monitoring and control.
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Introduction
Streptococcus suis is a bacterium that causes substantial losses
in the pig industry worldwide and is a common cause of zoo-
notic bacterial meningitis, mainly affecting working-age men in
pig-rearing areas, particularly in Southeast Asia.1,2 The number
of reported cases rapidly increased to >1600 cases in a 2013
review of publications.3 More than 500 cases had been reported
from Viet Nam in research settings in some national and provin-
cial hospitals by 2015.4–8 These reports include only cases that
were identified and reported, likely representing only a small
fraction of the real burden. The most common clinical presenta-
tion of human S. suis infection is purulent meningitis, severe
sepsis, endocarditis, endophthalmitis and arthritis.2 In addition
to substantial mortality (13% on average, 0–6% in Viet Nam),
important sequelae include severe to complete sensineural
hearing loss with or without vestibular dysfunction.2
Despite the proliferation of data on S. suis infection and
increased awareness within scientific and medical disciplines of
this important infection, there has been no reduction in inci-
dence, particularly in Asian countries.3 This may be explained by
the lack of awareness among community members and policy-
makers of the impact of the disease in terms of both health and
economic consequences caused by premature deaths and long-
term disability. To our knowledge, there have not been any
research attempts to quantify the health and economic burden
of S. suis infection in humans globally. Underutilization or lack of
microbiology capacity in local hospitals, the use of antibiotics
© The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
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prior to hospital admission and sampling and poor continuity of
care present a real challenge in attempts to quantify the burden
of disease in resource-restricted settings such as Viet Nam. This
study aimed to support policymakers in prioritizing and justifying
resource allocation for the prevention and control of S. suis by
quantifying the annual incidence, the disease burden in
disability-adjusted life years (DALYs) and the economic impact
of human S. suis infection in Viet Nam.
Materials and methods
We estimated the burden of disease and economic impact of
human S. suis infection following an incidence-based approach:
all health and economic consequences attributable to the infec-
tion were captured through an outcome tree describing the cau-
sal relationships between these consequences and the initial
infection. The impact of all consequences was attributed to one
point in time when the infection occurred.9 The annual inci-
dence of disease was estimated using a model-based approach
with input data from the national surveillance of notifiable dis-
eases for the years 2011–2014. Data on mortality and disability
were obtained through a systematic literature review2 and a
prospective follow-up study of patients with laboratory-confirmed
S. suis infection admitted to the National Hospital for Tropical
Diseases (NHTD) in Hanoi, Viet Nam between November 2014 and
October 2015.10
Annual incidence
S. suis has been a notifiable communicable disease in Viet Nam
since 2011. Health facilities are required to report cases of
culture confirmed S. suis infection within 24 h of identification to
the local health preventive unit. However, many provinces do
not report any S. suis cases, as shown in their reports for the
period 2011–2014 (Figure 1). It is likely that this is due to under-
diagnosis and/or underreporting, because pig farming is a com-
mon practice and pork is consumed by >98% of households in
Viet Nam and in research studies S. suis is the most frequent
causative agent identified in adult meningitis.11 Incidence data
from non-reporting provinces were therefore treated as missing
data in this analysis and imputed using a systematic and valid
approach as described below.
The incidence was modelled using a set of predictor vari-
ables for which data were available at the provincial level
from the national General Statistics Office of Viet Nam (http://
www.gso.gov.vn). These variables were selected based on
their possible association with disease incidence or with the
probability of data missingness, including geographic region,
human population density, pig density, proportion of rural
population, number of hospitals, income, immigration rate,
outmigration rate and proportion of skilled workers (see
Supplementary Table 1). We used a multiple imputation
approach, which is fundamentally a repeated imputation pro-
cess taking m draws from a posterior predictive distribution
for the missing data under a specific imputation model.12 All
nine predictors were included in the imputation model, which
generates m=100 imputed datasets with 10 iterations for
each imputation cycle. The total disease incidence was calcu-
lated for each imputed dataset separately and the results
were pooled across 100 imputed datasets to produce the
mean incidence with a variance that took into account both
within-dataset and between-dataset variation (more details
in the Supplementary Data).
Figure 1. Distribution of S. suis cases reported to the national surveillance system by province in Viet Nam in 2011–2014.
V. T. L. Huong et al.
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Disease outcome tree
We constructed an operational outcome tree (Figure 2)
describing the main clinical states and outcomes resulting in
morbidity/mortality. The acute phase represents all possible
clinical presentations including meningitis during hospitaliza-
tion, while the post-infectious phase includes the transitory
states that patients surviving S. suis infection might go
through after hospital discharge. The two main long-term dis-
ease sequelae (hearing loss and vestibular dysfunction) were
captured in this outcome tree. These can occur in patients
with and without meningitis, although the rate of hearing
loss is higher in meningitis compared with non-meningitis
cases. Hearing impairment can occur alone or accompanied
by vestibular dysfunction. Vestibular dysfunction without
hearing loss is uncommon in S. suis infection, therefore this
outcome was excluded from the outcome tree. Outcomes
affecting organs other than the hearing and vestibular system
(e.g. vision loss) may occur, however, such outcomes are
uncommon and data are insufficient to quantify the incidence
of these outcomes from both the available literature and our
follow-up study.
A gamma distribution was assumed for the incidence of
disease and subsequent health states, with shape and scale
parameters derived from the estimated mean and uncer-
tainty interval. Transitioning probabilities (fixed values) and
the durations of different health states (average and range)
were derived using Vietnamese data if a reasonable estimate
was available. Otherwise, estimates were obtained from the
literature through the systematic review (Table 1). The num-
bers of cases in each state were estimated from the simu-
lated annual incidence using probabilities of progressing from
one state to another. We applied a case fatality rate (CFR) of
12.8%, which was the pooled estimate in the meta-analysis
of all large studies.2 However, we also checked how the bur-
den estimates vary if applying a smaller CFR of 4%, the
pooled estimate for studies with meningitis patients. In the
follow-up study, all cases with severe hearing loss showed
vestibular dysfunction,10 therefore we did not consider the
impact of severe hearing loss without vestibular dysfunction
in S. suis survivors. Hearing loss was defined based on audi-
ometry, which measured the average of hearing thresholds
over four frequencies (0.5, 1, 2 and 4 kHz) in the better ear.10
We categorized hearing as normal (if the average was
<20 dB), mild (20–34 dB), moderate (35–49 dB), severe loss
(50–79 dB) and profound to complete loss (≥80–94 dB).
Burden of disease in DALYs
The DALY measure is the summation of the number of years of
life lost due to premature mortality (YLL) and the number of
years of healthy life lost due to disability (YLD) (Supplementary
Data). A disability weight between 0 (perfect health) and
1 (death) is used to adjust the years lived with disability in the
YLD measure for each health state. Neither age weighting nor
discounting was applied following the current practice in analys-
ing global burden of diseases.14 We applied the Viet Nam life
table for 200915 to calculate the remaining life expectancy for
each sex and age group. Disability weights were taken from the
Global Burden of Diseases study for the year 201313 (Table 1).
Estimates were presented for the following age groups by sex:
15–44 y, 45–59 y and ≥60 y (S. suis infection has not been
reported in children in Viet Nam). Uncertainty was determined
through Monte Carlo simulations by iteratively simulating ran-
dom values for each parameter according to its predefined dis-
tribution. Sensitivity analysis was performed using linear
regression of the overall DALY estimates against the simulated
values for the input parameters to identify parameters that
cause significant uncertainty in the overall DALY estimates.
Cost of illness
We quantified the economic impact using a cost-of-illness
approach from a patient’s perspective. Costs generated
throughout the lifetime of an incident S. suis case were summed
to obtain the total economic impact incurred. These included
direct medical costs (costs for any health care services for dis-
ease detection, treatment, continuing care and rehabilitation
related to the infection episode or associated sequelae), direct
non-medical costs (costs for travelling, food, accommodation
and any other costs related to the infection episode and asso-
ciated sequelae) and indirect costs (the value of the productivity
losses incurred by the patients and their informal caregivers
related to the infection episode and associated sequelae). The
productivity costs incurred by the patients’ informal caregivers
were included within the indirect costs and not the direct non-
medical costs (because in Viet Nam family members usually
stayed in the hospital to provide care to the patient).
Primary cost data were collected as part of the follow-up
prospective study at the NHTD.10 The NHTD is a public hospital
receiving government funding for overhead costs, including
labour costs and assets. Operational costs are covered by health
Figure 2. Outcome tree for S. suis infection in humans summarizing different states from acute phase to clinical outcomes of the disease.
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insurance and patient out-of-pocket payments. The insurance
coverage rate in Viet Nam is not high among near-poor people
(people having an income up to 1.5 times the poverty threshold):
26% compared with 63% for the national average coverage.16
Forty-seven patients with laboratory-confirmed S. suis infec-
tion between November 2014 and October 2015 at the NHTD
were interviewed at hospital discharge and at 3 months and
9 months after discharge. Cost data were collected from hos-
pital charts (formal hospital fees, insurance coverage) and inter-
views of patients and their relatives. Data collected from
interviews included any informal fees and other medical and
drug costs paid outside of standard hospital financial
regulations of the NHTD and non-medical costs arising from
hospitalization, such as food, transport and accommodations.
For indirect costs, we asked the respondents about any income
loss due to sickness and caregiving activities for both patients
and caregivers.
We estimated indirect costs (productivity loss) due to prema-
ture mortality and long-term disability as the product of time
loss and average potential earnings, taking a human capital
approach (details on cost calculations are provided in the
Supplementary Data).
To have a broader picture of the economic burden, we also
interviewed about other impacts, including the patient’s time
Table 1. Summary of parameters for estimating disease burden and economic impact of human S. suis infection in Viet Nam
Parameter Value Distribution Source
Annual disease incidence (per 100 000 population) Mean (95% UI) Gamma Simulated from surveillance data
2011 0.318 (0.306–0.331)
2012 0.324 (0.313–0.335)
2013 0.255 (0.250–0.261)
2014 0.249 (0.238–0.261)
Transition rate (%) Mean
Case fatality rate 12.8 Fixed Systematic review2
Hearing loss + VD Fixed Follow-up study10
Mild 0.266
Moderate 0.151
Severe 0.111
Profound/complete 0.288
Hearing loss without VDa Fixed Follow-up study10
Mild 0.134
Moderate 0.027
Duration (days) Mode (min, max) Beta-pert
Acute infectious episode 17.4 (13, 19.2) Systematic review2
Post-infectious phaseb 90 (15, 270) Follow-up study10
Disability weight Mean (95% UI) Beta GBD 201313
Acute episode 0.133 (0.088–0.190)
Post-infectious phase 0.219 (0.148–0.308)
Hearing loss + VDc
Mild 0.122 (0.083–0.166)
Moderate 0.137 (0.099–0.181)
Severe 0.253 (0.220–0.291)
Profound/complete 0.294 (0.263–0.330)
Hearing loss without VD
Mild 0.01 (0.004–0.019)
Moderate 0.027 (0.015–0.042)
Age of onset of acute episode (years) 49.18 Fixed Case seriesd
UI: uncertainty interval; VD: vestibular dysfunction; GBD: Global Burden of Disease.
aAll cases with severe to profound/complete hearing loss showed vestibular dysfunction as observed in the follow-up study.
bPost-infectious phase occurs after the acute phase of an infectious disease, including consequences such as fatigue, emotional lability and
insomnia. The lay description used in the Global Burden of Diseases 2013 was the person ‘is always tired and easily upset. The person feels pain
all over the body and is depressed’.
cThis was derived using a multiplicative method combining both the states of hearing loss and the state of vestibular dysfunction (see
Supplementary Data).
dAge of disease onset was estimated from a case series from 2011 to 2015 at the NHTD. Specific mean age at onset was calculated for all age
groups by sex for DALY calculations.
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(number of hours per week) spent on paid and unpaid work
before and after illness, the patient’s income earned before and
after illness and any consequences caused by the illness and its
sequelae. Unpaid work was defined as activities that the person
spent time on but does not get paid for, such as household
chores, shopping, childcare and voluntary work. However, these
were not included in the cost of illness calculations.
We performed a one-way sensitivity analysis to assess the
impact of uncertainty in each of the input parameters on the
total cost of disease. We varied one parameter at a time while
fixing the other parameters at their expected values.
Costs were collected and estimated at the prices of 2014–2015
(during the time of the follow-up study) in Vietnamese dong
(VND). The impact of inflation during this time period was not sig-
nificant and therefore was not adjusted for. We summarized the
costs as mean, median, minimum and maximum in US dollars; 1
million VND was equivalent to US$46.38 at the average exchange
rate between January 2014 and December 2015 (http://usd.fx-
exchange.com/vnd/exchange-rates-history.html). These costs were
used to estimate the total cost of illness for the years 2011–2014
(all expressed in 2014–2015 prices).
A 3% discount rate was applied to costs relating to long-term
sequelae and premature mortality occurring after 2014.17,18
Differences in costs were tested using the Welch two-sample t-
test, with unequal variances on a log scale.We used log-binomial
models to calculate age-adjusted prevalence ratios for being
unemployed between patients with and without long-term
sequelae. All data processing and analysis was performed using
R software (version 3.2.2; R Project for Statistical Computing,
Vienna, Austria).
Results
Annual incidence
The annual incidence was estimated at 0.318, 0.324, 0.255 and
0.249 cases per 100 000 population in 2011, 2012, 2013 and
2014, respectively. Assessment of convergence and distributions
of residuals showed the imputation was appropriate and valid
data have been imputed to the overall incidence (Supplementary
Figure 1 and 2). The estimated incidence rates were about two to
three times the rate directly calculated from the number of cases
reported to the surveillance system (0.08–0.15 cases per 100 000
population).
DALYs
The estimated disease burden of human S. suis infection in
Viet Nam was 1832, 1866, 1467 and 1401 DALYs lost in the
years 2011, 2012, 2013 and 2014, respectively (Table 2). The
DALYs burden was disproportionately distributed towards men
and people of working age. Overall, deaths due to acute infec-
tion account for the largest proportion of DALYs lost each year
(>50%) when using the CFR of 12.8% (Figure 3). If we used a
low CFR of 4%, the number of DALYs was reduced to 1189,
1212, 952 and 933, respectively, with 25% due to premature
deaths.
Disability due to profound or complete hearing loss with ves-
tibular dysfunction caused 506, 516, 406 and 397 DALYs in
these years, accounting for more than half of the total YLD each
year. The remaining disability was caused by other conditions,
including acute illness, post-infectious period and mild to mod-
erate hearing loss without vestibular involvement. Uncertainty
in disability weight of profound or complete hearing loss had
the greatest influence on the overall uncertainty in the esti-
mated DALYs (Supplementary Figure 3).
Cost of illness
The mean direct cost per S. suis infection episode was US$1635
(95% confidence interval [CI] 1352 to 1923), of which patients
had to pay a mean medical cost of US$1046 and non-medical
costs of US$589 (Table 3). Only half of the patients had insurance
coverage (24/47), and among those insured, the coverage levels
varied from 29% to 96% of the total hospital costs. Patients with-
out health insurance had to pay about twice the medical costs of
Table 2. Annual total disease burden and economic impact of human S. suis infection in Viet Nam
Year DALYa (overall) DALY by age group DALY by sex Direct costsb
(thousand $US)
Indirect costsb (thousand $US)
15–44 y 45–59 y ≥60 y Male Female Mortality Morbidity
2011 1832 887 835 110 1584 248 499 1225 1576
(1777–1888) (142–1204) (1176–1274) (1513–1638)
2012 1866 904 850 112 1613 253 499 1260 1620
(1811–1923) (143–1195) (1218–1302) (1567–1674)
2013 1467 710 669 88 1267 200 386 1004 1291
(1425–1511) (112–914) (982–1025) (1264–1319)
2014 1401 680 638 83 1212 189 370 991 1275
(1357–1446) (105–897) (946–1036) (1216–1333)
aDALYs are presented as means; those in brackets are the 95% credibility intervals calculated through Monte Carlo simulations.
bCosts are presented as means; those in brackets are the lower and upper bound based on the 95% uncertainty interval of the estimated
annual incidence generated through the imputation process. Primary direct costs were collected in 2014–2015.
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patients with insurance (US$1428 versus US$677, Welch t-test,
p<0.001). Patients with long-term severe hearing loss paid signifi-
cantly higher medical costs than those with non-severe impair-
ment (US$765 versus US$505, p=0.03). No significant difference
was observed in direct non-medical costs between groups by
insurance and by hearing impairment severity.
The annual direct cost was approximately US$370 000–500
000 between 2011 and 2014 in total (Table 2). The indirect cost
was US$2 270 000–2 880 000, representing approximately 85%
of the total cost. Sensitivity analysis showed that most of the
variation in the total cost of illness was due to direct
hospitalization costs, average national income level, rate of
severe hearing loss in patients, case fatality rate and rate of
productivity reduction in hearing impaired patients (Figure 4).
Twenty-three of 41 patients (56%) who had a paid occupa-
tion before hospitalization returned to their occupation by
9 months after hospital discharge (Table 4). Among these, eight
had to change occupation due to health conditions (reduced
hearing, dizziness, weakness), which prevented them from per-
forming heavy duties such as construction work. The reported
number of paid work hours per week was also significantly
reduced (mean reduction of 13.6 h [95% CI 2.6 to 24.7],
Figure 3. Estimated annual DALY burden caused by acute infection, post-infectious phase and long-term sequelae (hearing loss with vestibular dys-
function [H-V] and hearing loss without vestibular dysfunction) of human S. suis infection in Viet Nam in 2011–2014. Dark blue bar represents YLLs
due to premature mortality; yellow bar represents YLDs.
V. T. L. Huong et al.
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p=0.02, paired t-test). Patients who had moderate to complete
hearing loss had a 2.6 times higher risk of unemployment at
9 months after discharge compared with other patients (64%
versus 23%, prevalence ratio 2.6 [95% CI 1.2 to 7.9]).
The disease was reported to greatly impact patients and their
family in most cases (43/45 patients at discharge and 20/46 after
9 months) (see Supplementary Table 2). Reduced productivity in
paid work was the leading factor causing the negative impact, fol-
lowed by an increase in health-related expenses. Many families
resorted to taking out loans to cover hospital costs (33/45 at dis-
charge) and 9/31 families continued to pay loan interest 9 months
after discharge (see Supplementary Table 3).
Discussion
This study aimed to quantify the burden of human illness
caused by S. suis infection in Viet Nam and showed a significant
impact on affected patients and their families in this low- and
middle-income country (LMIC). Most patients were the main
family income generator and had non-skilled occupations,
including household farming and manual labour. The affected
families had to pay a higher hospital cost than their annual
per capita family income. This cost was also higher than the
average annual per capita income of the general population
(31 680 000 VND or US$1471).19
S. suis infection created significant catastrophic health
expenditures for the families, aggravated by the significant loss
in productivity due to long-term hearing loss and dizziness.
Families affected by illness often needed to make decisions
about treatment and manage their financial resources to pay
for the treatment and replace the lost income.20 This was par-
ticularly the case for families who did not have any savings and
for whom farming was their primary work for subsistence.
Studies have shown that families in LMICs depend on their
established social networks for their coping capacity, and the
poorest families often have the weakest support network for
finding financial resources they need in these circumstances.20–22
Poor families are often forced to borrow money from high-interest
sources, as was reported by many families in our study.
We utilized a combination of data sources, including surveil-
lance data, retrospective hospital data and prospective patient
follow-up data, and used a statistically principled method of
multiple imputation to estimate the true values for incidence
rates based on reported surveillance data. We assumed that
incidence data for the provinces that had a report of zero cases
were likely missing data and these values could be estimated
based on a set of relevant geographic, demographic and socio-
economic indicators for which data were available. Even when
data were imputed for potentially missing data in the surveil-
lance system, our estimate of 0.25–0.32 S. suis cases per
100 000 population in Viet Nam in the years 2011–2014 is likely
a conservative estimate of incidence. A previous prospective
study provided a slightly higher estimate of 0.57 cases per
100 000 person-years (95% CI 0.47 to 0.70) in the adult popula-
tion during 2007–2010,23 equivalent to 0.422 cases per 100 000
person-years for the whole population. However, this study was
only conducted in 12 hospitals in the southern and central parts
of Viet Nam, which may be an overrepresentation of the areas
with high disease incidence.
We used an incidence-based approach to quantify the bur-
den of S. suis infection. This approach is appropriate for studying
the health burden of infectious diseases with long-term seque-
lae and has been used previously for enteric pathogens.9,24
Using a prevalence-based approach, it would have been more
difficult to include the impact of hearing loss with and without
Table 3. Direct costs per case of S. suis infection in patients hospitalized at the NHTD collected in 2014–2015 in Viet Nam
Type of direct costs Mean ($US) Median ($US) Range ($US)
Medical costs (total costa) 1431 1260 347–3094
Antibiotics 531 473 107–1448
Metabolites 292 356 97–422
Other drugs 94 62 24–498
Laboratory 226 225 59–381
Bed 147 90 19–1461
Services 41 12 3–304
Imaging 20 5 2–153
Consumables 34 34 12–90
Medical costs (paid by patientb) 1046 928 74–3094
Non-medical costsc 589 417 0–1855
Total direct costsd 1635 1375 473–4832
aTotal medical costs (and the breakdown components underneath) included the out-of-pocket payments made by patients plus the payments
covered by any health insurance scheme.
bThese medical costs are the out-of-pocket payments made by the patients and excluded payments covered by health insurance.
cThese included all direct non-medical costs paid by patients.
dTotal direct costs included all direct medical and non-medical costs paid by patients, excluding payments made by health insurance.
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vestibular dysfunction, because calculating the prevalence of
such sensory problems attributable to a specific cause is impos-
sible in the context of Viet Nam. Long-term consequences of
infectious diseases are often neglected in the assessments of
disease burden.25,26 In the analysis of national burden of dis-
ease and injury for Viet Nam in 2008, only 13% of the total bur-
den was attributed to infectious diseases and neonatal and
maternal conditions, of which >75% were caused by mortality
due to such communicable conditions.27 This implies a lack of
data for long-term morbidity of infectious diseases in this
country.
We reported a higher cost of hospitalization for S. suis infec-
tion than the costs documented in previous studies for meningi-
tis in children in Viet Nam (US$44 per suspected case, US$164
Figure 4. One-way sensitivity analysis showing the effect of changing the expected value in each parameter on the total cost of human S. suis infec-
tion in Viet Nam in 2011.
Table 4. Impact of S. suis infection on work and income of infected patients hospitalized at the NHTD in 2014–2015 in Viet Nam
Variable Summary values
Patients in paid work before illness 41/47 (87%)
Patients returning to paid work after 9 months since dischargea 23/41 (56%)
Among those with severe hearing loss 5/14 (36%)
Among those with non-severe hearing loss 16/25 (64%)
Impact of diseases on time for work (mean, median, minimum–maximum)
Time between hospital discharge and returning to paid workb (months) 3.2, 3, 0.5–9
Time spent on paid work per week before illnessc (hours) 51, 56, 14–84
Time spent on paid work per week at 9 months post-dischargec (hours) 40.5, 45, 14–7
Time spent on unpaid work per week before illness (hours) 10, 4.5, 0–63
Time spent on unpaid work per week at 9 months post-discharge (hours) 15.6, 14, 0–56
Impact of diseases on income ($US) (mean, median, minimum–maximum)
Patient’s monthly income before illnessc 278, 139, 9–1484
Income loss due to hospitalizationd 173, 139, 0–696
Patient’s monthly income at 9 months post-dischargec 237, 209, 28–742
Per capita family monthly income before illnessc 79, 70, 5–209
Per capita family monthly income at 9 months post-dischargec 83, 79, 9–241
aChi-square test for difference in probability of returning to paid work by 9 months between those with severe hearing loss and non-severe
hearing loss had a p-value of 0.09.
bAmong patients who returned to paid work by 9 months after hospital discharge.
cCalculated among patients in paid work only.
dIncludes both income loss of the patient and caregivers.
V. T. L. Huong et al.
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per definite case in a provincial hospital in 200628 and US$300
per case in a central hospital in 2012).29 Comparison of the
costs across different studies has limitations due to different
frames of cost analysis, year of estimation and level of health
care settings. However, the higher hospital costs found in our
study are likely to reflect the disease severity and sequelae of
S. suis infection.
Very few studies in LMICs have calculated the indirect costs
due to illness. Here we estimated income and productivity loss
due to hospitalization, long-term sequelae and premature mortal-
ity from S. suis infection. Our estimation for indirect costs was
based on the human capital approach, which has been criticized
for overestimating the economic impact of disease compared with
the friction cost approach, which only counts the production loss
while finding a replacement worker.30 However, the latter
approach was not suitable for estimating the cost of illness to the
affected households, as the majority of S. suis patients are in infor-
mal employment (such as household farming). Our cost estimates
were sensitive to a number of input parameters, especially
disease-related factors, which reflects the wide clinical spectrum
and degree of severity of this infection in humans. The variation in
the annual average national income from 2011 to 2014 also
affected our cost estimates, however, this impact is likely to
represent the actual economic fluctuations in the fast-changing
market economy of the country. The cost estimates were also
influenced by the level of productivity reduction in hearing-
impaired individuals and further studies are warranted to investi-
gate this impact in an LMIC such as Viet Nam.
Findings from our estimation of health and economic burden
should be interpreted in light of potential limitations. First, our
direct cost estimates were based on data collected at a referral
hospital, which may not be representative for cases of S. suis
infection treated at lower-level hospitals. The median length of
stay for our patients was 23 d (range 9–56), which is higher
than the average of 17 d (range 0–77) reported in the litera-
ture,2 although still within the same range. Second, we did not
include long-term audiologic assessments and fitting of assist-
ive devices in the direct medical costs or special education and
rehabilitation, including vocational training, for hearing impaired
people in the indirect costs. These could not be captured during
the follow-up period of the study.
In conclusion, this study demonstrates a considerable burden
of disease and economic impact of S. suis infection on patients
and families in an LMIC like Viet Nam. The high burden was
beyond the acute infection and associated hospitalizations and
encompassed the long-term consequences caused by prema-
ture mortality and disabling sequelae, especially when most of
the infected individuals were the main breadwinners of their
families. This work highlights the importance of improving dis-
ease monitoring and surveillance to provide accurate data for
public health planning and interventions. It also provides con-
solidating evidence for strengthening disease prevention activ-
ities in the country.
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